22. Omicron news: current risks, future prospects

In the month since my post on Omicron we have learned a great deal more about it. The big news is the discovery that Omicron has developed a way to get inside cells never seen before in COVID viruses. Because some types of cells allow this entry and others don’t, the course of the pandemic may be altered. And I’ll give you an update on what we’ve learned about the risks with Omicron and the changes in treatment regimens that must be used to treat it. But first, here’s the bottom line, with the details to follow.

Bottom line:

We now know that Omicron has figured out a new way of entering cells – it attaches tightly to their outside and then tricks them into protecting it with a layer of fat and pulling it inside. It does this best with the cells that line your nasal cavity – the very cells that are thought to release the virus bursts that infect other people. So it’s very contagious. Omicron is also pulled into the types of cells that line the nasal cavity of some animals and so we will need to monitor this closely.

How many of us will get hospitalized or die? As with all forms of COVID, Omicron is far, far more dangerous to older adults than to kids, including unvaccinated young children. Nonetheless, if all adults were vaccinated the number of COVID deaths from Omicron would likely be even less than deaths from the flu. But because so many adults are not vaccinated and Omicron is so contagious, many will get sick and die.

Treatments that work against Omicron

How protective are vaccines against Omicron? As I wrote last month, very, very protective. The current data suggests that vaccines reduce the chance of dying by an astonishing 95%. It is much harder to estimate how well vaccines protect against being hospitalized. This is because the majority of people who test positive in hospitals are not there because of COVID. That is, they are hospitalized for other conditions and then routine testing can give a positive COVID result. This is especially true of young children, who rarely are hospitalized with a COVID diagnosis. So, it is very difficult to get data on the number of people put into hospitals because of COVID. It would not be surprising to find out that vaccines are more than 90% effective at keeping you out of the hospital due to illness caused by COVID. 

But what if you are hospitalized because of serious COVID symptoms? Omicron has changed the treatment landscape. In the last post I told you that we defeat Omicron with our biological memory systems rather than with the antibodies that circulate in our bodies. Basically, antibodies triggered by vaccines or old infections do not really recognize Omicron very well. This is also true of the antibodies in treatments developed in drug company laboratories, so the current infusions can no longer be used effectively. This is a serious problem because antibody infusions have been an important medical treatment, especially for the unvaccinated. It is easy to re-design the infusions to target Omicron, but that will take time. Fortunately, the pills I discussed in the last 2 posts, such as paxlovid, still work against Omicron. But we will need to be patient as these become more available and we gain real world experience in their use.

How Omicron works and why this matters

As I said, Omicron has developed a way of entering cells not seen before with any variant of COVID. As far as the implications for humankind are concerned, there are bad and good aspects of this change. All other virus variants attach to the outside of certain cells, shape-shift and then shed their spiky coats. This leads to the release of virus m-RNA to the inside of the cells. The cell’s machinery is then hijacked and forced to make many copies of the virus. But Omicron doesn’t work exactly like this. Instead, it takes advantage of how some cells capture useful nutrients to bring them inside. Omicron tricks some types of cells into “capturing” it and pulling it inside, coat and all. We don’t yet know exactly what happens next except that more copies of the virus are made. 

Not all cells are equally susceptible to being entered in these 2 different ways and this is very important in understanding what Omicron does to us. Omicron is very good at getting into the cells in your nose but not very good at getting inside the cells of your lungs. These 2 places play very different roles in COVID diseases. The nose is thought to be the main place where contagious respiratory viruses are released, and this helps Omicron be very contagious. But virus in the lungs leads to the most dangerous COVID symptoms so that makes Omicron somewhat less dangerous.

Omicron is also very fast. It gets into your cells faster, induces symptoms faster and if you get really sick this also happens faster. But like a sprinter who drops from exhaustion at the finish line, Omicron has somewhat of a hard time keeping going. So, the burst of Omicron viruses appears to be smaller than bursts coming from existing variants that don’t use the new entry pathway. This may be fortunate for us, as it could possibly help minimize the spread of COVID to our internal organs.

What might an Omicron future look like? 

The changed way that Omicron enters cells leads to new uncertainty about what will happen in the future. COVID-19 is believed to have started out in horseshoe bats, which are a natural reservoir that provides a place where mutant viruses can begin to be produced (see Spring 2020 posts). The original mutant that thrived in human cells was so altered that it could not go back and easily re-infect bats. But now, scientists have found that Omicron’s use of the capture and enter pathway allows it to infect cells isolated from some animals, including horseshoe bats, chickens and mice. Whether this will happen in real animals is as yet unknown but it is definitely something that needs to be monitored.

The appearance of Omicron almost certainly means that we will need to re-design booster shots and take them periodically. The re-design of m-RNA vaccines is very easy and making an even more effective Omicron booster should be no problem. As discussed in prior posts, we already do a re-design every year for the flu vaccine booster. So it’s possible that COVID and flu vaccinations will co-exist for a while; scientists are already designing a single shot that would deliver both vaccines. Right now, the COVID vaccines are more effective than the flu vaccines so it may turn out that COVID will become the lesser danger of the two.

But there is one caveat here and it’s a big one. If you’re not vaccinated, COVID, even in the form of Omicron, is significantly more dangerous than the flu. And although vaccinated people can spread Omicron, the spread is far worse from an un-vaccinated person. So if you know someone who is resisting vaccination you might send them this post. Or just ask them to sacrifice their personal preference for the sake of protecting their community and the nation from the spread of COVID.

Jay Gralla, January 26, 2022

Published by jgcovidblog

Jay Gralla is an emeritus professor of Biochemistry at UCLA. He has done research at Yale, Harvard, the Pasteur Institute, MIT and of course UCLA.